Quetiapine Sustained Release in Treatment of Delirium Induced by Cerebral Metastasis

While haloperidol represents the first-line treatment of delirium, some studies have shown that atypical antipsychotics could be used as an efficacious treatment in delirium management. This article reports a case of a delirious patient, treated effectively and quickly with Quetiapine sustained rele...

Descripción completa

Detalles Bibliográficos
Autores principales: Messina, Antonino, Fogliani, Anna Maria
Formato: Texto
Lenguaje:English
Publicado: S. Karger AG 2010
Materias:
Published: July 2010
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920009/
https://www.ncbi.nlm.nih.gov/pubmed/20740206
http://dx.doi.org/10.1159/000318598
_version_ 1782185231985410048
author Messina, Antonino
Fogliani, Anna Maria
author_facet Messina, Antonino
Fogliani, Anna Maria
author_sort Messina, Antonino
collection PubMed
description While haloperidol represents the first-line treatment of delirium, some studies have shown that atypical antipsychotics could be used as an efficacious treatment in delirium management. This article reports a case of a delirious patient, treated effectively and quickly with Quetiapine sustained release with negligible side effects.
format Text
id pubmed-2920009
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-29200092010-08-25 Quetiapine Sustained Release in Treatment of Delirium Induced by Cerebral Metastasis Messina, Antonino Fogliani, Anna Maria Case Rep Oncol Published: July 2010 While haloperidol represents the first-line treatment of delirium, some studies have shown that atypical antipsychotics could be used as an efficacious treatment in delirium management. This article reports a case of a delirious patient, treated effectively and quickly with Quetiapine sustained release with negligible side effects. S. Karger AG 2010-07-16 /pmc/articles/PMC2920009/ /pubmed/20740206 http://dx.doi.org/10.1159/000318598 Text en Copyright © 2010 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No-Derivative-Works License (http://creativecommons.org/licenses/by-nc-nd/3.0/). Users may download, print and share this work on the Internet for noncommercial purposes only, provided the original work is properly cited, and a link to the original work on http://www.karger.com and the terms of this license are included in any shared versions.
spellingShingle Published: July 2010
Messina, Antonino
Fogliani, Anna Maria
Quetiapine Sustained Release in Treatment of Delirium Induced by Cerebral Metastasis
title Quetiapine Sustained Release in Treatment of Delirium Induced by Cerebral Metastasis
title_full Quetiapine Sustained Release in Treatment of Delirium Induced by Cerebral Metastasis
title_fullStr Quetiapine Sustained Release in Treatment of Delirium Induced by Cerebral Metastasis
title_full_unstemmed Quetiapine Sustained Release in Treatment of Delirium Induced by Cerebral Metastasis
title_short Quetiapine Sustained Release in Treatment of Delirium Induced by Cerebral Metastasis
title_sort quetiapine sustained release in treatment of delirium induced by cerebral metastasis
topic Published: July 2010
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920009/
https://www.ncbi.nlm.nih.gov/pubmed/20740206
http://dx.doi.org/10.1159/000318598
work_keys_str_mv AT messinaantonino quetiapinesustainedreleaseintreatmentofdeliriuminducedbycerebralmetastasis
AT foglianiannamaria quetiapinesustainedreleaseintreatmentofdeliriuminducedbycerebralmetastasis

Ejemplares similares